Anti-cardiolipin 항체와 Cardiolipin의 결합에 미치는 β2-GP1의 영향
Effect of β2-GP1 on the Binding of Anti-cardiolipin Antibodies to Cardiolipin
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background: Anti-cardiolipin antibody (Anti-CL Ab) is one of the various anti- phospholipid antibodies (Anti-PL Abs) and found in the plasma of patients with systemic lupus erythematosus (SLE), atherosclerosis, and other infectious diseases. While anti-PL Abs found in the sera of patients with infectious diseases bind directly to CL, binding of anti-PL Abs to CL circulating in the sera of patients with autoimmune diseases is mediated by β2-glycoprotein 1 (β2-GP1). The purpose of this study is to investigate the effect of β2-GP1 on the antigen binding assay of anti-CL Abs present in the sera of patients with atherosclerosis, which has been known as one of autoimmune diseases. Methods: ELISA was performed with sera containing anti-CL Abs from three patients with atherosclerosis in the presence or absence of β2-GP1 or FBS. Results: Reactivity of anti-CL Abs to CL was increased in the presence of β2-GP1 or FBS in a dose dependent manner. Conclusion: β2-GP1 or FBS could be used as co-factor in CL ELISA with anti-CL Abs present in the sera of patients with atherosclerosis. It is suggested that anti-CL Abs found in atherosclerosis patients are similar in terms of antigen binding property to those circulating in the patients with autoimmune diseases, not to infectious diseases. (Immune Network 2004;4(3):161-165)
참고문헌 (12)
- "Anti- phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation", pp.4120~4124 (1990)
- "Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179", pp.457~462 (1994)
- "β2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum 37", pp.1453~1461 (1994)
- "Atherosclerosis as an autoimmune disease: an update.", 22(12), pp.665~669 (2001)
- "Atherosclerosis, autoimmunity, and systemic lupus erythematosus.", 104(16), pp.1876~1877 (2001)
- "Autoimmunity and atherosclerosis.", 138, pp.444~449 (1999)
- "Antiphospholipid antibodies and myocardial infarction.", 7, pp.132~134 (1998)
- "Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease.", 238(5), pp.437~443 (1995)
- "Autoantibodies to modified LDLs and other phospholipid-protein complexes as markers of cardiovascular diseases.", 247(3), pp.381~384 (2000)
- "Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F -VI levels and the extent of atherosclerosis in ApoE-deficient mice modulation by vitamin E.", 97(2), pp.459~464 (2001)
- "Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin.", 66(6), pp.629~632 (1991)
- "Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179", pp.457~462 (1994)